SCHEMBL9533640

SCHEMBL9533640

CN(C)Sc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ALDH1A1 P00352 4/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 2/20 0.36
KCNN4 O15554 1/20 0.36
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
FAAH O00519 1/20 0.34
PHGDH O43175 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
ACHE P22303 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18499751 0.78 MGLL (0.41) MGLLMAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL24628141 0.76 MAOA (0.53) HSD17B10ALDH1A1MAOAMAOB
SCHEMBL611875 0.76 HPGD (0.58) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL19149930 0.74 MAOA (0.39) MGLLMAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL18602960 0.74 ALDH1A1 (0.39) MGLLMAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL11767314 0.72 HPGD (0.41) MGLLMAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL24038373 0.72 ACHE (0.48) MAPTSMN1; SMN2ALDH1A1MAPK1MEN1
SCHEMBL10333922 0.72 MGLL (0.55) MGLLMAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL7190169 0.72 NR1H2 (0.50) MAPTHPGDSMN1; SMN2HSD17B10ALDH1A1
SCHEMBL19274515 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0313458-B1 IMIDAZO(2,1-B)BENZOTHIAZOLES AND THEIR ACID ADDITION SALTS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-08-11 EP claimed
EP-0313458-A2 Imidazo(2,1-b)benzothiazoles and their acid addition salts, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1989-04-26 EP claimed
US-20220386614-A1 OXADIAZOLINE COMPOUND OR SALTS THEREOF, AGRICULTURAL AND HORTICULTURAL BACTERICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME NIHON NOHYAKU CO., LTD. (JP) 2022-12-08 US disclosed
CN-111303150-B High-efficiency narrow-half-peak-width aggregation state luminescent material 苏州大学 2021-10-19 CN disclosed
CN-111303150-A High-efficiency narrow-half-peak-width aggregation state luminescent material 苏州大学 2020-06-19 CN disclosed
US-9758534-B2 Organoaminosilanes and methods for making same VERSUM MATERIALS US, LLC (US) 2017-09-12 US disclosed
CN-104072484-B Nitrogen-(4-(aromatic thiohydroxy)-1 hydrogen-indazole-3-base)-1-(heteroaromatic replacement) methylene imine compounds and pharmaceutically acceptable salt and its preparation method and application thereof 渤海大学 2016-07-06 CN disclosed
CN-102171287-A Dispersed composition, polymerizable composition, light shielding color filter, solid-state imaging element, liquid crystal display device, wafer-level lens, and imaging unit FUJIFILM CORP 2011-08-31 CN disclosed
CN-1798538-A Photostable organic sunscreen composition MERCK PATENT GMBH (DE) 2006-07-05 CN disclosed
EP-0313458-B1 IMIDAZO(2,1-B)BENZOTHIAZOLES AND THEIR ACID ADDITION SALTS, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1993-08-11 EP disclosed
EP-0313458-A2 Imidazo(2,1-b)benzothiazoles and their acid addition salts, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them ROUSSEL-UCLAF (FR) 1989-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220386614-A1 OXADIAZOLINE COMPOUND OR SALTS THEREOF, AGRICULTURAL AND HORTICULTURAL BACTERICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME BROX, CYP51A1, TBCD MGLL 1250/4885MAPT 2331/4885HPGD 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.